Biomedicine and Chemical Sciences
2023, Volume 2, Issue 2 : 76-82 doi: https://doi.org/10.48112/bcs.v2i2.456
Research Article
The Role of Gold Nanoparticles/Au-PEG-PAMAM as Drug Delivery System for Treatment of Breast Cancer
 ,
Received
Feb. 2, 2023
Revised
March 15, 2023
Accepted
March 20, 2023
Published
April 1, 2023
Abstract

To enhance the cellular uptake and chemotherapeutic efficacy of a current chemotherapeutic medication, a nanoparticle drug carrier technology has been designed. Due to their distinctive electrical and optical characteristics, gold nanoparticles (Au NPs) have recently demonstrated intriguing medical and military uses. In the event that they come into touch with a biological system, little is known about their biocompatibility. Metallic nanoparticles have been successfully utilized for a kind of biological applications.  A drug delivery system known as Au – PEG – PAMAM – DOX was produced by conjugating the dendrimer with the anti-cancer chemical doxorubicin (DOX) via an amide bond. The amount of DOX released from Au – PEG – PAMAM – DOX at a natural pH was negligible, but this amount significantly increased in an environment with a weak acidic milieu, according to studies on the release of medicines from acellular sources. A research into the intracellular release of the medication was carried out with the assistance of confocal laser scanning microscopy (CLSM). Recently conjugation to the nanosystem, in vitro viability experiments revealed an increase in the associated DOX cytotoxicity that could not be attributable to carrier components. This indicates that the effectiveness of the DOX was increased. In light of this, it has been hypothesized that the newly created pH-triggered multifunctional Au NPs- DOX nanoparticle system could pave the way for a viable platform for the intracellular delivery of a range of anticancer medicines. In the current study, the common Au NPs synthesis techniques and their well-established uses in diverse needs, particularly in biological sensing applications.

Keywords
REFERENCES
  1. Atun, R., Jaffray, D. A., Barton, M. B., Bray, F., Baumann, M., Vikram, B., ... & Gospodarowicz, M. (2015). Expanding global access to radiotherapy. The Lancet Oncology, 16(10), 1153-1186. https://doi.org/10.1016/S1470-2045(15)00222-3
  2. Bentzen, S. M. (2006). Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nature Reviews Cancer, 6(9), 702-713. https://doi.org/10.1038/nrc1950
  3. Bugno, J., Hsu, H. J., & Hong, S. (2015). Recent advances in targeted drug delivery approaches using dendritic polymers. Biomaterials science, 3(7), 1025-1034. https://doi.org/10.1039/C4BM00351A
  4. Crooks, R. M., Zhao, M., Sun, L., Chechik, V., & Yeung, L. K. (2001). Dendrimer-encapsulated metal nanoparticles: synthesis, characterization, and applications to catalysis. Accounts of chemical research, 34(3), 181-190. https://doi.org/10.1021/ar000110a
  5. Dreaden, E. C., Austin, L. A., Mackey, M. A., & El-Sayed, M. A. (2012). Size matters: gold nanoparticles in targeted cancer drug delivery. Therapeutic delivery, 3(4), 457-478. https://doi.org/10.4155/tde.12.21
  6. Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008). A review of stimuli-responsive nanocarriers for drug and gene delivery. Journal of controlled release, 126(3), 187-204. https://doi.org/10.1016/j.jconrel.2007.12.017
  7. Gao, J., Huang, X., Liu, H., Zan, F., & Ren, J. (2012). Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging. Langmuir, 28(9), 4464-4471. https://doi.org/10.1021/la204289k
  8. Golshan, M., Salami-Kalajahi, M., Roghani-Mamaqani, H., & Mohammadi, M. (2017). Poly (propylene imine) dendrimer-grafted nanocrystalline cellulose: Doxorubicin loading and release behavior. Polymer, 117, 287-294. https://doi.org/10.1016/j.polymer.2017.04.047
  9. Gürbüz, M. U., Öztürk, K., Ertürk, A. S., Yoyen-Ermis, D., Esendagli, G., Çalış, S., & Tülü, M. (2016). Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers. Journal of Biomaterials science, Polymer edition, 27(16), 1645-1658. https://doi.org/10.1080/09205063.2016.1226044
  10. He, H., Li, Y., Jia, X. R., Du, J., Ying, X., Lu, W. L., ... & Wei, Y. (2011). PEGylated Poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials, 32(2), 478-487. https://doi.org/10.1016/j.biomaterials.2010.09.002
  11. Huang, F., Watson, E., Dempsey, C., & Suh, J. (2013). Real-time particle tracking for studying intracellular trafficking of pharmaceutical nanocarriers. Cellular and Subcellular Nanotechnology: Methods and Protocols, 211-223. https://doi.org/10.1007/978-1-62703-336-7_20
  12. Iacovita, C., Stiufiuc, R., Radu, T., Florea, A., Stiufiuc, G., Dutu, A., ... & Lucaciu, C. M. (2015). Polyethylene glycol-mediated synthesis of cubic iron oxide nanoparticles with high heating power. Nanoscale research letters, 10(1), 1-16. https://doi.org/10.1186%2Fs11671-015-1091-0
  13. Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011). Nanoparticle PEGylation for imaging and therapy. Nanomedicine, 6(4), 715-728. https://doi.org/10.2217/nnm.11.19
  14. Kurniasih, I. N., Keilitz, J., & Haag, R. (2015). Dendritic nanocarriers based on hyperbranched polymers. Chemical Society Reviews, 44(12), 4145-4164. https://doi.org/10.1039/C4CS00333K
  15. Lane, L. A., Qian, X., Smith, A. M., & Nie, S. (2015). Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo. Annual review of physical chemistry, 66, 521-547. https://doi.org/10.1146/annurev-physchem-040513-103718
  16. Lazarovits, J., Chen, Y. Y., Sykes, E. A., & Chan, W. C. (2015). Nanoparticle–blood interactions: the implications on solid tumour targeting. Chemical Communications, 51(14), 2756-2767. https://doi.org/10.1039/C4CC07644C
  17. Lee, K. Y., Wang, Y., & Nie, S. (2015). In vitro study of a pH-sensitive multifunctional doxorubicin–gold nanoparticle system: Therapeutic effect and surface enhanced Raman scattering. RSC Advances, 5(81), 65651-65659. https://doi.org/10.1039/C5RA09872F
  18. Li, X., Takashima, M., Yuba, E., Harada, A., & Kono, K. (2014). PEGylated PAMAM dendrimer–doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy. Biomaterials, 35(24), 6576-6584. https://doi.org/10.1016/j.biomaterials.2014.04.043
  19. Liu, L., Tang, Y., Dai, S., Kleitz, F., & Qiao, S. Z. (2016). Smart surface-enhanced Raman scattering traceable drug delivery systems. Nanoscale, 8(25), 12803-12811. https://doi.org/10.1039/C6NR03869G
  20. Moustaoui, H., Movia, D., Dupont, N., Bouchemal, N., Casale, S., Djaker, N., ... & Spadavecchia, J. (2016). Tunable design of Gold (III)–Doxorubicin Complex–PEGylated nanocarrier. The golden doxorubicin for oncological applications. ACS applied materials & interfaces, 8(31), 19946-19957. https://doi.org/10.1021/acsami.6b07250
  21. Rosa, S., Connolly, C., Schettino, G., Butterworth, K. T., & Prise, K. M. (2017). Biological mechanisms of gold nanoparticle radiosensitization. Cancer Nanotechnology, 8(1), 1-25. https://doi.org/10.1186/s12645-017-0026-0
  22. Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(1), 7-30. https://doi.org/10.3322/caac.21442
  23. Tian, F., Bonnier, F., Casey, A., Shanahan, A. E., & Byrne, H. J. (2014). Surface enhanced Raman scattering with gold nanoparticles: effect of particle shape. Analytical Methods, 6(22), 9116-9123. https://doi.org/10.1039/C4AY02112F
  24. Venkatesan, R., Pichaimani, A., Hari, K., Balasubramanian, P. K., Kulandaivel, J., & Premkumar, K. (2013). Doxorubicin conjugated gold nanorods: a sustained drug delivery carrier for improved anticancer therapy. Journal of Materials Chemistry B, 1(7), 1010-1018. https://doi.org/10.1039/C2TB00078D
  25. Wolinsky, J. B., & Grinstaff, M. W. (2008). Therapeutic and diagnostic applications of dendrimers for cancer treatment. Advanced drug delivery reviews, 60(9), 1037-1055. https://doi.org/10.1016/j.addr.2008.02.012
  26. Zhang, L., Zhu, S., Qian, L., Pei, Y., Qiu, Y., & Jiang, Y. (2011). RGD-modified PEG–PAMAM–DOX conjugates: In vitro and in vivo studies for glioma. European journal of pharmaceutics and biopharmaceutics, 79(2), 232-240. https://doi.org/10.1016/j.ejpb.2011.03.025
  27. Zhang, W. L., Li, N., Huang, J., Yu, J. H., Wang, D. X., Li, Y. P., & Liu, S. Y. (2010). Gadolinium‐conjugated FA‐PEG‐PAMAM‐COOH nanoparticles as potential tumor‐targeted circulation‐prolonged macromolecular MRI contrast agents. Journal of applied polymer science, 118(3), 1805-1814. https://doi.org/10.1002/app.32494
  28. Zhong, Y., Wang, C., Cheng, R., Cheng, L., Meng, F., Liu, Z., & Zhong, Z. (2014). cRGD-directed, NIR-responsive and robust AuNR/PEG–PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo. Journal of Controlled Release, 195, 63-71. https://doi.org/10.1016/j.jconrel.2014.07.054
  29. Zong, S., Wang, Z., Chen, H., Yang, J., & Cui, Y. (2013). Surface enhanced Raman scattering traceable and glutathione responsive nanocarrier for the intracellular drug delivery. Analytical chemistry, 85(4), 2223-2230. https://doi.org/10.1021/ac303028v
Recommended Articles
Original Article Open Access
A FRAMEWORK OF MONOCLONAL ANTIBODIES AND RELATED PRODUCTION ENGINEERING
2025, Volume 4, Issue 4 : 26-34
Research Article Open Access
Design and Synthesis Ligands Tetradents Substituted with Halogenes in α- Position and Conjugation with Riboflavin (Bioconjugates)
2022, Volume 1, Issue 2 : 47-56
DOI: https://doi.org/10.48112/bcs.v1i2.85
Research Article Open Access
The Role of Vitamin D and Zinc In Facing COVID-19 Injury
2022, Volume 1, Issue 1 : 6-10
DOI: https://doi.org/10.48112/bcs.v1i1.76
Research Article Open Access
Spectroscopic and Thermal Studies of Some Palladium(II) Complexes with 2-amino-4-(4-subsistuted phenyl)thiazole Derivatives
2022, Volume 1, Issue 2 : 78-82
DOI: https://doi.org/10.48112/bcs.v1i2.104
Biomedicine and Chemical Sciences journal thumbnail
Volume 2, Issue 2
Citations
3 Views
0 Downloads
Share this article
License
Copyright (c) Biomedicine and Chemical Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Biomed. Chem. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Biomedicine and Chemical Sciences Logo
Biomedicine and Chemical Sciences
About Us
Biomedicine and Chemical Sciences (BCS), an international journal, publishes double blind peer-reviewed full-length, original papers, reviews or letters. BCS covers the latest developments in various fields of biomedicine such as cardiology, immunology, genetics, environmental health, neurology, oncology and toxicology
Support
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright Biomedicine and Chemical Sciences (BCS). All Rights Reserved.